Operating margin moved 118 bp higher
Operating margin changed +118 basis points from the comparable as-filed period.
39.57%→40.75%2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →EXEL financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cost of revenue increased 41.2%
Cost of revenue changed +41.2% from the comparable as-filed period.
$18.6M→$26.2M2 prior comparisons
Operating income increased 13.5%
Operating income changed +13.5% from the comparable as-filed period.
$236.5M→$268.4M2 prior comparisons
Capital expenditure increased 67.9%
Capital expenditure changed +67.9% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$1.5M→$2.5M2 prior comparisons
Operating cash-flow margin moved 607 bp lower
Operating cash-flow margin changed -607 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
48.57%→42.50%2 prior comparisons
Free-cash-flow margin moved 620 bp lower
Free-cash-flow margin changed -620 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
48.32%→42.12%2 prior comparisons
Revenue increased 10.2%
Revenue changed +10.2% from the comparable as-filed period.
$597.8M→$658.7M2 prior comparisons
Free-cash-flow proxy decreased 3.9%
Free-cash-flow proxy changed -3.9% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$288.8M→$277.5M2 prior comparisons
Net income increased 12.7%
Net income changed +12.7% from the comparable as-filed period.
$193.6M→$218.1M2 prior comparisons
Gross margin moved 88 bp lower
Gross margin changed -88 basis points from the comparable as-filed period.
96.89%→96.02%2 prior comparisons
Operating cash flow decreased 3.6%
Operating cash flow changed -3.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$290.3M→$280.0M2 prior comparisons
Selling, general & administrative increased 25.0%
Selling, general & administrative changed +25.0% from the comparable as-filed period.
$123.7M→$154.6M2 prior comparisons
Research & development increased 5.2%
Research & development changed +5.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$199.2M→$209.5M2 prior comparisons
Working capital decreased 11.5%
Working capital changed -11.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$1.0B→$909.7M4 prior comparisons
Capex / revenue moved 13 bp higher
Capex / revenue changed +13 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
0.25%→0.38%2 prior comparisons
R&D / revenue moved 152 bp lower
R&D / revenue changed -152 basis points from the comparable as-filed period.
33.32%→31.80%2 prior comparisons
Operating cash flow / net income decreased 14.4%
Operating cash flow / net income changed -14.4% from the comparable as-filed period.
1.5→1.282 prior comparisons
Current assets decreased 5.8%
Current assets changed -5.8% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$1.4B→$1.3B4 prior comparisons
SBC / revenue moved 81 bp lower
SBC / revenue changed -81 basis points from the comparable as-filed period.
5.17%→4.36%2 prior comparisons
Working capital / assets moved 23 bp lower
Working capital / assets changed -23 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
36.43%→36.19%4 prior comparisons
Inventory / revenue moved 5 bp lower
Inventory / revenue changed -5 basis points from the comparable as-filed period.
4.58%→4.53%2 prior comparisons
Inventory increased 9.0%
Inventory changed +9.0% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$27.4M→$29.9M4 prior comparisons
Stock-based compensation decreased 7.0%
Stock-based compensation changed -7.0% from the comparable as-filed period.
$30.9M→$28.7M2 prior comparisons
Operating cash flow / net income increased 447.6%
Operating cash flow / net income changed +447.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
0.27→1.452 prior comparisons
Revenue increased 10.6%
Revenue changed +10.6% from the comparable as-filed period.
$568.3M→$628.7M2 prior comparisons
Total assets decreased 6.9%
Total assets changed -6.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$2.7B→$2.5B4 prior comparisons
Operating cash-flow margin moved 4033 bp higher
Operating cash-flow margin changed +4033 basis points from the comparable as-filed period.
8.62%→48.95%2 prior comparisons
Free-cash-flow margin moved 3974 bp higher
Free-cash-flow margin changed +3974 basis points from the comparable as-filed period.
8.12%→47.87%2 prior comparisons
Net income increased 14.7%
Net income changed +14.7% from the comparable as-filed period.
$184.8M→$212.1M2 prior comparisons
Working capital / assets moved 410 bp higher
Working capital / assets changed +410 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
31.54%→35.64%4 prior comparisons
Capex / revenue moved 58 bp higher
Capex / revenue changed +58 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
0.50%→1.08%2 prior comparisons
Current assets increased 5.9%
Current assets changed +5.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$1.2B→$1.3B4 prior comparisons
Research & development increased 5.8%
Research & development changed +5.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$200.4M→$212.0M2 prior comparisons
Inventory increased 22.3%
Inventory changed +22.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$23.5M→$28.7M4 prior comparisons
Working capital increased 5.2%
Working capital changed +5.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$844.7M→$888.9M4 prior comparisons
R&D / revenue moved 154 bp lower
R&D / revenue changed -154 basis points from the comparable as-filed period.
35.26%→33.72%2 prior comparisons
SBC / revenue moved 117 bp lower
SBC / revenue changed -117 basis points from the comparable as-filed period.
6.35%→5.18%2 prior comparisons
Selling, general & administrative increased 9.5%
Selling, general & administrative changed +9.5% from the comparable as-filed period.
$134.9M→$147.6M2 prior comparisons
Inventory / revenue moved 44 bp higher
Inventory / revenue changed +44 basis points from the comparable as-filed period.
4.13%→4.57%2 prior comparisons
Stock-based compensation decreased 9.7%
Stock-based compensation changed -9.7% from the comparable as-filed period.
$36.1M→$32.6M2 prior comparisons
Current ratio decreased 1.6%
Current ratio changed -1.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
3.51→3.464 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.